Economic Atlas
Companies/Aridis Pharmaceuticals, Inc.
Company profile

Aridis Pharmaceuticals, Inc.

OTC: ARDS · Healthcare · Biotechnology
PublicHQ Los Gatos, CA · Santa ClaraCIK 0001614067Reports USD
#750 of 1,422 Healthcare companies by revenuetop-quartile growth
EA Score
——
Revenue TTM
$20.1M
Rev growth YoY (TTM)
+2227.6%
Net income (FY)
-$30.4M
Employees
37
as of 2026-08-30
Market cap
$4.5k
as of 2026-08-30

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$3.1M$3.1M2022
Net income-$30.4M-$30.4M2022
Operating income-$30.0M-$30.0M2022
Total assets$14.7M$14.7M2022
Liabilities$38.9M$38.9M2022
Equity-$24.2M-$24.2M2022

Revenue trend

FY2018 – FY2022 · USD
FY18
FY20
FY20
FY21
FY22
FY22
FY22
FY22

Revenue by segment

Filed disclosures · FY2019
By product
License0%
By geography

Not disclosed.

The read

What is Aridis Pharmaceuticals, Inc.’s revenue?

Aridis Pharmaceuticals, Inc. booked $3.1M in FY2022 revenue, growing 65% year over year — faster than most Healthcare companies we track, at a -982.6% net margin.

Peers · Healthcare
TransCanna Holdings Inc.——Aptevo Therapeutics Inc.35DAvitar, Inc.——Dyadic International, Inc.39DPolarean Imaging plc——Numinus Wellness Inc.——
Neighbors
Santa Clara →
NVIDIA Corporation$215.9B90AApple Inc.$416.2B84B+Alphabet Inc.$402.8B81B+Broadcom Inc.$63.9B76B+Advanced Micro Devices, Inc.$34.6B78B+Cisco Systems, Inc.$56.7B85A
Key facts
CEOVu L. Truong
SectorHealthcare
IndustryBiotechnology
HeadquartersLos Gatos, CA
ExchangeOTC: ARDS
Employees37
IPO date2018-08-14
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.